Effect of chromium picolinate on modified forced swimming test in diabetic rats: Involvement of serotonergic pathways and potassium channels

Basic and Clinical Pharmacology and Toxicology

Volumn 98, Issue 2, 2006, Pages 155-159

  Khanam, Razia ^a   Pillai, K K ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM PICOLINATE; DRINKING WATER; GLIMEPIRIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FORCED SWIMMING TEST; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; IMMOBILIZATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLYBURIDE; INSULIN; MALE; PICOLINIC ACIDS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; SEROTONIN; STREPTOZOCIN; SWIMMING;

ANIMALIA;

EID: 33645085305     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_288.x     Document Type: Article

References (14)

1. 2A receptors Psychopharmacol. 2002 159 432 436
2. Cameron O. G. Z. Kfonfol J. F. Greden B. J. Carrol Hypothalamic- pituitary-adrenocortical activity in patients with diabetes mellitus Arch. Gen. Psychiatry 1984 41 1090 1095
3. Chowdhury S. K. Pandit P. Roychowdury B. Bhattacharya Role of chromium in human metabolism, with special reference to type 2 diabetes J. Assoc. Physicians India 2003 51 701 715
4. Cryan J. F. M. E. Page I. Lucki Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swimming test Eur. J. Pharmacol. 2002 436 197 205
5. Elizabeth H. B. K. Wayne V. K. Michael R. Carolyn E. S. Greg O. Malia C. Paul J. L. Evette B. Terry Y. Bessie Relationship of depression and diabetes Self-care, medication Adherence, and Preventive care Diab. Care 2004 27 2154 2160
6. Guo W. Y. K. G. Todd M. Bourin M. Hascoet The additive effects of quinine on antidepressant drugs in the forced swimming test in mice Psychopharmacol. 1995 121 173 179
7. Guo W. K. Todd M. Bourin M. Hascoet F. Kouadio Additive effects of glyburide and antidepressants in the forced swimming test: Evidence for the involvement of potassium channel blockade Pharmacol. Biochem. Behav. 1996 54 725 730
8. Horacek J. M. Kuzmiakova C. Hoschi M. Andel R. Bahbonh The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers Psychoneuroendocrinol. 1999 24 785 787
9. Jonathan R. T. D. A. Kurian M. C. Kathryn M. N. McLeod Effectiveness of Chromium in atypical depression: A placebo-controlled trial Biol. Psychiatr. 2003 53 261 264
10. Leonard E. E. Effects of depression on work loss and disability bed days in individuals with diabetes Diab. Care 2004 27 1751 1753
11. McCarty M. F. Enhancing central and peripheral insulin activity as a strategy for treatment of endogenous depression-an adjuvant role for chromium picolinate Med. Hypotheses 1994 43 247 252
12. McLeod M. N. B. N. Gaynes R. N. Golden Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients J. Clin. Psychiatr. 1999 60 237 240
13. Shinde U. A. R. K. Goyal Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats J. Cell. Mol. Med. 2003 3 322 329
14. Van Tilburg M. A. C. C. McCaskill J. D. Lane C. L. Edwards A. Bethel M. N. Feinglos R. S. Surwit Depressed mood is a factor in glycemic control in type 1 diabetes Psychosom. Med. 2001 63 551 555